Department of Health Clinical Trials Department of Health RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses
TARRYTOWN, N.Y., Jan. 12, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Department of Health and Human Services (HHS) and the Department of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 12, 2021 Category: Pharmaceuticals Source Type: clinical trials

Horyzons: Implementation in Clinical Practice
Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorders;   Unspecified Schizophrenia Spectrum and Other Psychotic Disorder Intervention:   Device: Horyzons USA Sponsors:   University of North Carolina, Chapel Hill;   North Carolina Department of Health and Human Services Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2020 Category: Research Source Type: clinical trials

Protocol for a randomized controlled trial evaluating the impact of the Nurse-Family Partnership ’s home visiting program in South Carolina on maternal and child health outcomes
This study is a randomized controlled trial evaluating the impact of the Nurse-Family Partnership ’s expansion in South Carolina. The scientific trial was made possible by a “Pay for Success” program embedded within a 1915(b) Waiver from Medicaid secured by the South Carolina Department of Health and Human Services. This protocol describes study procedures and defines primary and secondary health-related outcomes that can be observed during the intervention period (including pregnancy through the child’s first 2 years of life). Primary study outcomes include (1) a composite indicator for adverse birth outcomes inc...
Source: Trials - December 4, 2020 Category: Research Source Type: clinical trials